世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035511

AI を活用した創薬および臨床試験市場レポート 2023-2033

Visiongain

AI-Enabled Drug Discovery and Clinical Trials Market Report 2023-2033

発刊日 2023/06/30

言語英語

体裁PDF/267ページ

ライセンス/価格267ページ

0000035511

Single - 1 Year License
(Team License - Up to 6 Users) - 1 Year License
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数6人)をご検討ください。
※詳しくはお問い合わせください。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

コンポーネント別予測(サービス、ソフトウェア)、用途別(臨床試験、医薬品設計、データ集計と分析、医薬品特性評価、バイオマーカー研究、その他)、治療分野別(腫瘍学、心血管疾患、感染症、神経変性疾患、代謝性疾患、その他)、エンドユーザー別(製薬会社およびバイオ医薬品会社、受託研究機関(CRO)、その他)、および地域および主要な国内市場分析に加え、主要企業の分析、およびCOVID-19の影響と回復パターンの分析

ヘルスケアにおける AI アプリケーションの意識の高まりが市場の成長を促進

ヘルスケア サービスにおける AI アプリケーションの台頭により、AI 対応ソリューションに対する人々の認識と受容性が高まっています。したがって、より多くの製薬会社がこれらのソリューションを自社の創薬プロセスや臨床試験プロセスに組み込もうとしています。AI ベースのドラッグデリバリーソリューションは、製薬業界でますます人気が高まっています。これらのソリューションには、人工知能テクノロジーを使用して、より効率的かつ効果的な薬物送達方法を開発することが含まれます。ドラッグデリバリーにおける AI の使用は、コストを削減し、薬剤の有効性と安全性を向上させ、より良い患者転帰を提供することにより、業界を変革する可能性があります。

レポート詳細

目次

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to AI-Enabled Drug Discovery and Clinical Trials Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Demand for Personalized Medicine
3.2.1.2 Advancements in Technology
3.2.1.3 Growing Awareness of AI in Healthcare
3.2.1.4 Cost-effectiveness of AI-enabled Solutions
3.2.2 Market Restraining Factors
3.2.2.1 Lack of Skilled Personnel to Hamper the Market Growth
3.2.2.2 Limited Data Availability is a Major Challenge in Adoption of AI-enabled Solutions
3.2.2.3 Challenges Associated with Integration of New AI-enabled Solution with Existing Infrastructure
3.2.2.4 Ethics and Data Privacy Issues Hindering the Market Growth
3.2.2.5 Regulatory Hurdles Restraining the Global Market Growth
3.2.3 Market Opportunities
3.2.3.1 Improved Patient Outcomes
3.2.3.2 Increased Adoption Of AI-Enabled Solution By Pharma & Biopharma Companies For Clinical Trials
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Components
4.1 Key Findings
4.2 Components Segment: Market Attractiveness Index
4.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
4.4 Services
4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Software Solutions
4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.2 Market Share by Region, 2023 & 2033 (%)

5 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
5.4 Clinical Trials
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Drug Design
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Data Aggregation and Analysis
5.6.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Drug Characterization
5.7.1 Market Size by Region, 2023-2033 (US$ Million)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Biomarker Research
5.8.1 Market Size by Region, 2023-2033 (US$ Million)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Others
5.9.1 Market Size by Region, 2023-2033 (US$ Million)
5.9.2 Market Share by Region, 2023 & 2033 (%)

6 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Therapeutic Area
6.1 Key Findings
6.2 Therapeutic Area Segment: Market Attractiveness Index
6.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
6.4 Oncology
6.4.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Cardiovascular Diseases
6.5.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Infectious Diseases
6.6.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Neurodegenerative Diseases
6.7.1 Market Size by Region, 2023-2033 (US$ Million)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Metabolic Diseases
6.8.1 Market Size by Region, 2023-2033 (US$ Million)
6.8.2 Market Share by Region, 2023 & 2033 (%)
6.9 Others
6.9.1 Market Size by Region, 2023-2033 (US$ Million)
6.9.2 Market Share by Region, 2023 & 2033 (%)

7 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by End-User
7.1 Key Findings
7.2 End-User Segment: Market Attractiveness Index
7.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-User
7.4 Pharmaceutical & Biopharmaceutical Companies
7.4.1 Market Size by Region, 2023-2033 (US$ Million)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Contract Research Organizations (CROs)
7.5.1 Market Size by Region, 2023-2033 (US$ Million)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Others
7.6.1 Market Size by Region, 2023-2033 (US$ Million)
7.6.2 Market Share by Region, 2023 & 2033 (%)

8 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America AI-Enabled Drug Discovery and Clinical Trials Market Analysis
9.1 Key Findings
9.2 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
9.3 North America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
9.5 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
9.6 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
9.7 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
9.8 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
9.9 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Analysis
9.10 Canada AI-Enabled Drug Discovery and Clinical Trials Market Analysis

10 Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.1 Key Findings
10.2 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
10.3 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
10.5 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
10.6 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
10.7 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
10.8 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
10.9 Germany AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.10 UK AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.11 France AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.12 Italy AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.13 Spain AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.14 Russia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
10.15 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis

11 Asia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.1 Key Findings
11.2 Asia AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
11.3 Asia AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Asia AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
11.5 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
11.6 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
11.7 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
11.8 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
11.9 Japan AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.10 China AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.11 India AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.12 Australia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.13 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Analysis
11.14 Rest of Asia AI-Enabled Drug Discovery and Clinical Trials Market Analysis

12 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.1 Key Findings
12.2 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
12.3 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
12.5 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
12.6 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
12.7 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
12.8 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
12.9 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.10 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.11 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Analysis
12.12 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis

13 MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis
13.1 Key Findings
13.2 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
13.3 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
13.4 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
13.5 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
13.6 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
13.7 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
13.8 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
13.9 GCC AI-Enabled Drug Discovery and Clinical Trials Market Analysis
13.10 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Analysis
13.11 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis

14 Company Profiles
14.1 Company Share Analysis, 2022
14.2 Strategic Outlook
14.3 IBM Watson
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2019 -2022
14.3.3.2 R&D, 2019-2022
14.3.3.3 Regional Market Shares, 2022
14.3.4 Service Benchmarking
14.3.5 Strategic Outlook
14.4 Saama Technologies
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Service Benchmarking
14.4.4 Strategic Outlook
14.5 PathAI
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Service Benchmarking
14.5.4 Strategic Outlook
14.6 GNS Healthcare
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Service Benchmarking
14.6.4 Strategic Outlook
14.7 Unlearn.AI, Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Service Benchmarking
14.7.4 Strategic Outlook
14.8 Novartis AG
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2020 -2022
14.8.4 Service Benchmarking
14.8.5 Strategic Outlook
14.9 Merck & Co., Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2019-2021
14.9.4 Service Benchmarking
14.9.5 Strategic Outlook
14.10 AbbVie Inc.
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2019-2021
14.10.4 Service Benchmarking
14.10.5 Strategic Outlook
14.11 Exscientia
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Service Benchmarking
14.11.4 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 AI-Enabled Drug Discovery and Clinical Trials Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 3 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 4 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 5 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 6 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Clinical Trials Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Drug Design Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Data Aggregation and Analysis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Drug Characterization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Biomarker Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Infectious Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Neurodegenerative Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Metabolic Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Pharmaceutical & Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Rest of Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 Strategic Outlook
Table 76 IBM Watson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 IBM: Service Benchmarking
Table 78 IBM: Strategic Outlook
Table 79 Saama Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Saama Technologies: Service Benchmarking
Table 81 Saama Technologies: Strategic Outlook
Table 82 PathAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 PathAI: Service Benchmarking
Table 84 PathAI: Strategic Outlook
Table 85 GNS Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 GNS Healthcare: Service Benchmarking
Table 87 GNS Healthcare: Strategic Outlook
Table 88 Unlearn.AI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Unlearn.AI: Service Benchmarking
Table 90 Unlearn.AI: Strategic Outlook
Table 91 Novartis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Novartis: Service Benchmarking
Table 93 Novartis: Strategic Outlook
Table 94 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Merck & Co. Inc.: Service Benchmarking
Table 96 Novartis: Strategic Outlook
Table 97 Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 AbbVie Inc.: Service Benchmarking
Table 99 Exscientia: Strategic Outlook
Table 100 Exscientia: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Exscientia: Service Benchmarking
Table 102 Exscientia: Strategic Outlook
?

List of Figures
Figure 1 AI-Enabled Drug Discovery and Clinical Trials Market Segmentation
Figure 2 AI-Enabled Drug Discovery and Clinical Trials Market by Component: Market Attractiveness Index
Figure 3 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
Figure 4 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area Market Attractiveness Index
Figure 5 AI-Enabled Drug Discovery and Clinical Trials Market by End-user: Market Attractiveness Index
Figure 6 AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index by Region
Figure 7 AI-Enabled Drug Discovery and Clinical Trials Market: Market Dynamics
Figure 8 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 9 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 10 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 11 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 12 AI-Enabled Drug Discovery and Clinical Trials Market: Porter’s Five Forces Analysis
Figure 13 AI-Enabled Drug Discovery and Clinical Trials Market: PEST Analysis
Figure 14 AI-Enabled Drug Discovery and Clinical Trials Market by Components: Market Attractiveness Index
Figure 15 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 16 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by Components, 2023, 2028, 2033 (%)
Figure 17 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Software Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
Figure 22 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 23 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by Application, 2023, 2028, 2033 (%)
Figure 24 Clinical Trials Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 25 Clinical Trials Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Drug Design Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 27 Drug Design Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Data Aggregation and Analysis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 29 Data Aggregation and Analysis Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Drug Characterization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Drug Characterization Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Biomarker Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Biomarker Research Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 35 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area: Market Attractiveness Index
Figure 37 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 38 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 39 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Cardiovascular Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Infectious Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 44 Infectious Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Neurodegenerative Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 Neurodegenerative Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Metabolic Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 48 Metabolic Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 50 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 AI-Enabled Drug Discovery and Clinical Trials Market by End-User: Market Attractiveness Index
Figure 52 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR %)
Figure 53 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by End-User, 2023, 2028, 2033 (%)
Figure 54 Pharmaceutical & Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 55 Pharmaceutical & Biopharmaceutical Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 57 Contract Research Organizations (CROs) Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 59 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 61 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 62 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 63 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 64 North America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 65 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 66 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 67 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 68 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
Figure 69 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 70 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 71 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 72 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 73 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 74 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 75 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 76 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 77 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 78 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 79 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 80 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 81 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 82 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
Figure 83 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 84 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 85 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 86 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 87 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 88 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 89 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 90 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 92 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 93 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 94 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 95 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 96 Asia AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 97 Asia AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 98 Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 99 Asia AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 100 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 101 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
Figure 102 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 103 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 104 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 105 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 106 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 107 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 108 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 110 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 111 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 112 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 113 Rest of Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 114 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 115 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 116 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 117 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 118 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 119 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
Figure 120 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 121 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 122 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 123 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 124 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 125 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 126 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 127 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 128 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 129 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 130 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
Figure 131 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 132 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 133 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 134 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
Figure 135 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
Figure 136 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 137 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
Figure 138 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 139 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 140 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
Figure 141 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
Figure 142 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 144 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 145 AI-Enabled Drug Discovery and Clinical Trials Market: Company Share Analysis, 2022
Figure 146 IBM: Net Revenue, 2019-2022 (US$ Million, AGR%)
Figure 147 IBM: R&D, 2019-2022 (US$ Million, AGR%)
Figure 148 IBM: Regional Market Shares, 2022
Figure 149 Novartis: Net Revenue, 2020-2022 (US$ Million, AGR%)
Figure 150 Merck: Net Revenue, 2019-2021 (US$ million, AGR %)
Figure 151 Net Revenue, 2019-2021 (US$ million, AGR %)

この商品のレポートナンバー

0000035511

TOP